drugset / Trial / NCT00399256

Improved Estimation of GFR by Cystatin C in Preventing Contrast Induced Nephropathy by NAC or Zn

NCT00399256

RandomizedParallel-groupDouble-blindPrevention

Summary

Background Prevention of contrast media (CM) induced nephropathy (CIN) by pharmacological prophylaxis (e.g. N-acetylcysteine; NAC) is controversially discussed. So far, in all interventional studies assessment of kidney function was based on measurements of serum creatinine although this surrogate biomarker has several limitations. We investigated the antioxidants NAC and zinc (Zn) for the prevention of CIN by monitoring concomitantly serum levels of creatinine and cystatin C.

Timeline

Start
2004-03
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 1.2 g Oral
Subject Zinc Sulfate Unknown 60 mg Oral